Bio
Rumiana Tenchov is an information scientist at CAS. She earned her Ph.D. and D.Sc. degrees in biophysics from the Bulgarian Academy of Sciences. Prior to joining CAS, she was a research faculty member at the Department of Molecular Biosciences of the Northwestern University.
Emerging Science
CAS Insights Report: New techniques in assisted reproductive technology
Breakthroughs in assisted reproductive technology could overcome infertility challenges.
Emerging Science
Co-occurring concepts reveal new research directions in immuno-oncology
Concept co-occurrence analysis shows the newest ideas in scientific discovery and drives innovation in immuno-oncology.
Drug Discovery
罕见病和孤儿病：联合疗法可以治疗吗？
包括药物再利用、细胞疗法和基因疗法在内的联合疗法如何改善罕见病的治疗。
Emerging Science
Decoding neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's
Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
Drug Discovery
Ending Alzheimer's: Emerging trends in biomarkers, gene therapy, and more
Biomarkers, personalized medicine and gene therapies are fueling research breakthroughs. Discover new treatments targeting genetics and protein buildup to manage this devastating disease.
Drug Discovery
Can we cure Huntington's? Research trends in PolyQ and rare diseases
While no cure exists for PolyQ diseases like Huntington's, new breakthroughs, therapies, and research could change that.
Emerging Science
Biomarkers: The key to earlier cancer detection and patient outcomes
CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
Biotechnology
How biomarkers unlock faster cancer detection, improving outcomes
As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
Drug Discovery
揭示抗体偶联药物 (ADCs) 的潜力
了解抗体药物偶联物 (ADC) 如何以其靶向性和效力彻底改变癌症治疗。 揭示抗体偶联药物 (ADCs) 的潜力
Emerging Science
重新想象衰老：探索抗衰老治疗策略的潜力
探索最新的抗衰老治疗策略，促进健康和长寿。 在我们的最新文章中了解干细胞疗法、透明质酸、抗衰老药物和基因疗法的最新研究，以及当前正在进行临床试验的管线分析。
Emerging Science
聚乙二醇化脂质纳米颗粒的终极指南
了解如何克服 PEG 免疫原性对聚乙二醇化脂质纳米颗粒药物递送安全性和有效性的影响这一挑战。 本文综述了目前解决 PEG 免疫原性的最新研究进展，从阐明抗 PEG 抗体生成的影响因素到开发新型药物载体或优化给药和剂量。
Emerging Science
是友非敌：肠道微生物组利于改善健康
肠道微生物组是一个由数万亿细菌组成的复杂生态系统，这些细菌存活在我们的消化道中，具有提供免疫力、改善心理健康和提供治疗选择等健康益处。 近年来，人们对微生物组疗法治疗各种疾病的潜力越来越感兴趣。 随着我们对肠道微生物组的理解不断加深，我们有望在未来几年看到微生物组疗法的更多进展。
Biotechnology
不断发展的外泌体：从无名小卒到后起之秀
A historical overview of the discovery of exosomes, key milestones in their rise, and why they will revolutionize the diagnostic and drug delivery fields in the future.
Safety
硝酸铵：提高产品安全，降低未来风险
硝酸铵有能力养活数十亿人，但如果储存不当，就像一枚等待发生的炸弹。我们怎样才能使这种肥料更安全？了解新兴科学、更安全的替代方案以及安全储存和运输的最佳实践。
Drug Discovery
新冠病毒变异株不断更迭，口罩技术如何创新？
COVID大流行暴露了口罩开发和生产方面的缺陷。创新对于减缓病毒新变种的传播至关重要。口罩有许多因素可以改进，本文重点关注改善过滤和微生物去除的新兴科学。
Drug Discovery
固有无序蛋白会成为COVID-19治疗的关键吗?
了解本质无序蛋白质的重要功能及其在 COVID-19 治疗中发挥的关键作用。
Emerging Science
肠道微生物组与抑郁和焦虑有何关联
肠道微生物群、肠道菌群或微生物组是生活在人类和其他动物消化道中的微生物。 虽然有些细菌与疾病相关，但另一些细菌对健康的许多方面都尤为重要。
Biotechnology
脂质纳米颗粒：癌症治疗的重要参与者
Learn more about the applications of lipid nanoparticles in cancer therapy, their therapeutic benefits, and their future within nanomedicine.
Emerging Science
应对全球疫苗分布挑战
COVID-19 疫苗生产受限于脂质纳米粒的产量，目前应用微流体技术已成功生产脂质纳米粒。
Sustainability
吃塑料的超级酶能解决严峻的塑料问题吗?
一篇关于微生物酶如何分解塑料的研究概述。如果没有微生物酶，塑料可能需要数百年时间才能降解。